On the Record · Apellis Pharmaceuticals
Apellis Pharmaceuticals subsidiaries, as it lists them
The subsidiaries Apellis Pharmaceuticals lists in its latest annual report, with the jurisdiction of each, linked to the filing.
Subsidiaries it lists
| Subsidiary | Jurisdiction |
|---|---|
| Apellis Australia Pty Ltd. | Australia |
| Apellis Austria GmbH | Austria |
| Apellis Bermuda Ltd. | Bermuda |
| Apellis Canada Inc. | Canada |
| APL DEL Holdings, LLC | United States |
| Apellis Europe B.V. | Netherlands |
| Apellis Germany GmbH | Germany |
| Apellis France S.A.S. | France |
| Apellis International GmbH | Switzerland |
| Apellis Ireland Ltd. | Ireland |
| Apellis Italy S.r.I. | Italy |
| Apellis Netherlands, B.V. | Netherlands |
| Apellis Schweiz GmbH | Switzerland |
| Apellis Sweden AB | Sweden |
| Apellis U.K. Limited | United Kingdom |
| Apellis MA Securities, Inc. | United States |
| APL Sales I LLC | United States |
| APL PRG I Corporation | United States |
| APLSPRJ MRS, Inc. | United States |
From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.
Read from Apellis Pharmaceuticals’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.